Pure Health Holding PJSC Income Statement

Financials in millions AED. Fiscal year is January - December.

Millions AED. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	27,312	25,848	16,399	12,486
Revenue Growth (YoY)	5.66%	57.62%	31.34%	-
Cost of Revenue	20,579	19,202	12,976	7,656
Gross Profit	6,733	6,646	3,423	4,830
Selling, General & Admin	4,775	4,669	2,762	2,326
Other Operating Expenses	-708.78	-316.99	-841.02	-1,378
Operating Expenses	4,066	4,352	1,921	948.35
Operating Income	2,666	2,294	1,502	3,881
Interest Expense	-852.69	-825.28	-78.22	-44.56
Interest & Investment Income	340.31	304.05	-	-
Other Non Operating Income (Expenses)	-12.16	-22.36	-39.26	-
EBT Excluding Unusual Items	2,142	1,750	1,384	3,837
Impairment of Goodwill	-	-	-	-0.27
Gain (Loss) on Sale of Investments	43.9	68.18	-	-
Gain (Loss) on Sale of Assets	12.23	25.37	-0.61	-19.11
Asset Writedown	43.34	-65.84	-	-7.01
Other Unusual Items	0.8	-	-	475.46
Pretax Income	2,242	1,778	1,384	4,286
Income Tax Expense	222.01	62.04	418.7	-
Earnings From Continuing Operations	2,020	1,716	964.95	4,286
Minority Interest in Earnings	-17.99	-4.09	-0.29	-567.45
Net Income	2,002	1,712	964.66	3,718
Net Income to Common	2,002	1,712	964.66	3,718
Net Income Growth	16.97%	77.44%	-74.06%	-
Shares Outstanding (Basic)	11,111	11,111	10,037	9,832
Shares Outstanding (Diluted)	11,111	11,111	10,037	9,832
Shares Change (YoY)	-0.00%	10.71%	2.08%	-
EPS (Basic)	0.18	0.15	0.10	0.38
EPS (Diluted)	0.18	0.15	0.10	0.38
EPS Growth	16.97%	60.27%	-74.59%	-
Free Cash Flow	3,990	3,442	2,142	3,955
Free Cash Flow Per Share	0.36	0.31	0.21	0.40
Dividend Per Share	-	0.031	-	-
Gross Margin	24.65%	25.71%	20.87%	38.68%
Operating Margin	9.76%	8.87%	9.16%	31.09%
Profit Margin	7.33%	6.62%	5.88%	29.78%
Free Cash Flow Margin	14.61%	13.31%	13.06%	31.67%
EBITDA	3,530	3,165	2,221	4,166
EBITDA Margin	12.92%	12.24%	13.54%	33.37%
D&A For EBITDA	863.47	870.94	719.19	284.93
EBIT	2,666	2,294	1,502	3,881
EBIT Margin	9.76%	8.87%	9.16%	31.09%
Effective Tax Rate	9.90%	3.49%	30.26%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.